Patent US3137625A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3137625A Expired / Lapsed US ⏱️ 0.0 years remaining

Diuretic combinations containing a thiazide and a mercurial

Assignee: LAKESIDE LAB Inc
•
Filing: 1961-01-09
•
Granted: 1964-06-16
•
Expires: 1981-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 John H Biel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 16:02
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/63; A61K31/635

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 94 words
THE METHOD OF INCREASING DIURESIS IN A HUMAN WHILE REDUCING POTASSIUM EXCRETION CAUSED BY ADMINISTRATION OF A THIAZIDE DIURETIC ALONE, AND WITHOUT PRODUCING THE SIDE EFFECTS CAUSED BY ADMINISTRATION OF AN ORALLY EFFECTIVE MERCURIAL DIURETIC ALONE, WHICH COMPRISES ORALLY ADMINISTERING TO A HUMAN A COMBINATION OF TRICHLOROMETHIAZIDE AND CHLOROMERODRIN, SAID COMBINTION CONTAINING SAID TRICHLOROMETHIAZIDE IN AN AMOUNT EFFECTIVE TO INCREASE DIURESIS AND CONTAINING THE SAID CHLORMERODRIN IN AN AMOUNT SUFFICIENT TO SUPPRESS POTASSIUM EXCRETION INDUCED BY SAID TRICHLOROMETHIAZIDE BUT IN AN AMOUNT BELOW THAT WHICH CAUSES SUFFICIENT ADVERSE SIDE EFFECTS IN THE GASTROINTESTINAL TRACT.
Claim 2
Independent Claim 94 words
THE METHOD OF INCREASING DIURESIS IN A HUMAN WHILE REDUCING POTASSIUM EXCRETION CAUSED BY ADMINISTRATION OF A THIAZIDE DIURETIC ALONE, AND WITHOUT PRODUCING THE SIDE EFFECTS CAUSED BY ADMINISTRATION OF AN ORALLY EFFECTIVE MERCURIAL DIURETIC ALONE, WHICH COMPRISES ORALLY ADMINISTERING TO A HUMAN A COMBINATION OF TRICHLOROMETHIAZIDE AND CHLOROMERODRIN, SAID COMBINTION CONTAINING SAID TRICHLOROMETHIAZIDE IN AN AMOUNT EFFECTIVE TO INCREASE DIURESIS AND CONTAINING THE SAID CHLORMERODRIN IN AN AMOUNT SUFFICIENT TO SUPPRESS POTASSIUM EXCRETION INDUCED BY SAID TRICHLOROMETHIAZIDE BUT IN AN AMOUNT BELOW THAT WHICH CAUSES SUFFICIENT ADVERSE SIDE EFFECTS IN THE GASTROINTESTINAL TRACT.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1967-06-16 1967-12-16 1968-06-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1971-06-16 1971-12-16 1972-06-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1975-06-16 1975-12-16 1976-06-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag